About Instil Bio (TIL)
Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a cell therapy pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. TIL therapies leverage... Read more
- USD10.34
- USD10.54
- USD10.34
- USD14.00
- -14.00%
- --
- 11.13k
- 71M
- 6.07
- -20.60%
Stock News
3 hours ago
Q1 2024 Equifax Inc Earnings Call
Yahoo
4 hours ago
ICE Announces Record Trading Activity in Murban Crude as ICE Futures Abu Dhabi Marks Third Anniversary
Yahoo
6 hours ago
Dow Jones Futures Fall As Israel Strikes Iran; Stock Market About To Break Power Trend
Yahoo
6 hours ago
Boyd Gaming: Below Intrinsic Value, High Potential For Online Revenue Growth
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
